Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

86.25
BATS BZX Real-Time Price
As of 11:52am ET
 -0.09 / -0.10%
Today’s Change
66.93
Today|||52-Week Range
86.90
+18.41%
Year-to-Date
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
10:40am / Zacks.com - Paid Partner Content
Amgen's Xgeva Myeloma Label Expansion sBLA Accepted by FDA
Jun 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod
8:18am / Zacks.com - Paid Partner Content
Novartis (NVS) Biosimilar of MabThera Approved in the EU
Jun 19 / Zacks.com - Paid Partner Content
Healthcare Rally Can't Save S&P 500 From Another Down Day
Jun 22 / TheStreet.com - Paid Partner Content
3 Biotech Stocks That More than Doubled Year to Date
Jun 19 / Zacks.com - Paid Partner Content
Nasdaq Leads Wall Street, Healthcare Stocks Rise on Senate Bill
Jun 22 / TheStreet.com - Paid Partner Content
Novartis Secures European Approval For Biosimilar Cancer Treatment Rixathon
Jun 19 / TheStreet.com - Paid Partner Content
Novartis Announces Positive Results for Cardiovascular Drug
Jun 22 / Zacks.com - Paid Partner Content
Google and Novartis Back Medicxi's New $300 Million Fund
Jun 16 / TheStreet.com - Paid Partner Content
Healthcare Leads as Stocks Turn Higher After Release of Senate Bill
Jun 22 / TheStreet.com - Paid Partner Content
Puma (PBYI) Stock Surges as Neratinib Nears FDA Approval
Jun 15 / Zacks.com - Paid Partner Content
Stock Futures Dip as Crude Oil Looks to Correct Days-Long Slide
Jun 22 / TheStreet.com - Paid Partner Content
Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx
Jun 15 / Zacks.com - Paid Partner Content
Novartis Shares Lead Swiss Market Higher After CANTOS Trial Success
Jun 22 / TheStreet.com - Paid Partner Content
Why Is ImmunoGen (IMGN) Stock Up 131% This Year?
Jun 15 / Zacks.com - Paid Partner Content
Ligand Gets Milestone Payment on Partner Drug FDA Approval
Jun 21 / Zacks.com - Paid Partner Content
Why is Alnylam's (ALNY) Stock Close to 100% this Year?
Jun 15 / Zacks.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Coherus Stock Plummets as FDA Rejects Neulasta Biosimilar
Jun 13 / Zacks.com - Paid Partner Content
Novartis Migraine Drug Accepted, AMD Positive in Phase III
Jun 21 / Zacks.com - Paid Partner Content
Novartis Presents Positive Data on CAR-T Cell Therapy Drug
Jun 12 / Zacks.com - Paid Partner Content
Gilead's (GILD) HBV Drug Vemlidy Receives Approval in Canada
Jun 20 / Zacks.com - Paid Partner Content
Why is Kite Pharma (KITE) Stock Up Close to 100% this Year?
Jun 09 / Zacks.com - Paid Partner Content